1. Home
  2. CXDO vs ENLV Comparison

CXDO vs ENLV Comparison

Compare CXDO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.19

Market Cap

223.1M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.93

Market Cap

258.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
ENLV
Founded
1995
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
258.7M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
CXDO
ENLV
Price
$6.19
$0.93
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$9.25
$13.00
AVG Volume (30 Days)
186.1K
565.3K
Earning Date
05-05-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
N/A
EPS
0.16
N/A
Revenue
$68,167,000.00
N/A
Revenue This Year
$38.52
N/A
Revenue Next Year
$19.22
N/A
P/E Ratio
$38.88
N/A
Revenue Growth
12.05
N/A
52 Week Low
$3.75
$0.66
52 Week High
$7.80
$2.10

Technical Indicators

Market Signals
Indicator
CXDO
ENLV
Relative Strength Index (RSI) 45.91 39.97
Support Level $6.08 $0.81
Resistance Level $6.73 $1.25
Average True Range (ATR) 0.27 0.09
MACD -0.03 -0.02
Stochastic Oscillator 31.38 10.72

Price Performance

Historical Comparison
CXDO
ENLV

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: